Related Experiment Video
Updated: Oct 7, 2025

04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.6K
Outcome after treatment for sebaceous carcinoma: A multicenter study
Eva Huis In 't Veld1, Ronald Keizer2, Nicoline Post3
1Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Journal of Surgical Oncology
|January 6, 2022
Summary
Sebaceous carcinoma (SC) is a rare, locally aggressive cancer. Positive resection margins and ocular tumors increase recurrence risk, while metastases are infrequent.
Area of Science:
- Oncology
- Dermatopathology
- Surgical Oncology
Background:
- Sebaceous carcinoma (SC) is a rare malignant neoplasm with limited long-term outcome data.
- Understanding SC behavior is crucial for effective patient management.
Purpose of the Study:
- To evaluate the long-term outcomes of patients undergoing surgical resection for sebaceous carcinoma.
- To identify prognostic factors associated with recurrence and metastasis.
Main Methods:
- A retrospective analysis of 100 patients with 103 SCs treated at four tertiary centers.
- Cumulative incidence curves were used to assess recurrence rates.
- Follow-up data were collected to determine rates of locoregional and distant metastases.
Main Results:
- The median age of patients was 72 years, with a median follow-up of 52 months.
- Local recurrence occurred in 16.5% of cases, with higher rates for (peri)ocular SCs and positive resection margins.
- Metastases were infrequent, with 8.7% developing lymph node metastases during follow-up.
Conclusions:
- Sebaceous carcinoma is a locally aggressive tumor.
- Positive resection margins and (peri)ocular location are significant risk factors for local recurrence.
- Distant or locoregional metastases are uncommon in SC patients.
Related Concept Videos
Skin Cancer
4.8K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

